Litigation (Drug Pricing Matters) (Details) - Mar. 31, 2024	Total	state
Multi District Litigation [Member]
Loss Contingencies [Line Items]
Number of states	44	44
Anticompetitive Conduct with Generic Drugs [Member]
Loss Contingencies [Line Items]
Number of states	45
Amended Anticompetitive Conduct with Generic Drugs [Member]
Loss Contingencies [Line Items]
Number of states	40